Martin F. Dietrich, MD, discusses the use of the CDK4/6 inhibitor trilaciclib to address myelosuppression associated with chemotherapy in small cell lung cancer. Martin F. Dietrich, MD, assistant ...
Version of Record: This is the final version of the article. This study utilized publicly available Hi-C data to ensemble a comprehensive set of breast cancer cell lines (luminal, Her2+, TNBC) with ...
Revised: This Reviewed Preprint has been revised by the authors in response to the previous round of peer review; the eLife assessment and the public reviews have been updated where necessary by the ...
In a new study published in Nature Communications titled, “The reference genome of the human diploid cell line RPE-1,” researchers from University of Rome La Sapienza have produced the first reference ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Between Aug 31, 2022, and ...
Plainly, people seeking a single-line phone plan should avoid major carriers like Verizon, AT&T, and T-Mobile and opt for mobile virtual network operators (MVNOs). From a value standpoint, MVNOs like ...
The body’s cells change their shape to close gaps such as wounds – with part of the cell flexing depending on the curve of the gap and the organisation of cell-internal structures, a new study reveals ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. The California Institute for Regenerative Medicine has for a decade owned a human ...
When we think of death, we imagine a final, irreversible end. But what if death is not as absolute as it seems? What if some parts of us — our cells, our tissues — continue to fight for survival, even ...
The global cell line development market size was valued at around USD 5.86 billion in 2024 and is expected to grow to approximately USD 6.44 billion in 2025. The market is projected to reach nearly ...
Indian solar manufacturer Premier Energies has commissioned a 1.2GW TOPCon solar cell manufacturing line at Fab City, Hyderabad, Telangana. According to the firm, the plant will achieve over 25% cell ...
Roche has demonstrated the power of combining two of oncology’s hottest modalities—bispecifics and antibody-drug conjugates (ADCs)—in a Lunsumio-Polivy regimen in large B-cell lymphoma (LBCL). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback